The global glucagon market is anticipated to grow at a considerable CAGR of 5.9% during the forecast period. Glucagon is a metabolic hormone that increases the glucose level in the blood with the support of the liver which rapidly converts glycogen into glucose. The glucagon is secreted by the pancreas, which is further converted into glucose and released in the blood. It is basically used in the treatment of disorders such as low blood sugar and others. The primary factor attributing to the growth of the market includes the rising government activities such as FDA approvals and others across the globe. The globe has witnessed a considerable increase in the number of diabetic patients, which has increased the requirement for improved drugs for treatment. Hence, the government of several countries is pushing pharmaceutical companies and drug manufacturers to develop new and enhanced glucagon, which directly propels the growth of the market.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/glucagon-market
For instance, in December 2020, the US FDA approved the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, for the treatment of severe hypoglycemia. Hypoglycemia is a condition of the very low blood sugar level, which primarily occurs in patients with diabetes mellitus. The drug is also indicated as a diagnostic aid in the radiologic examination of the stomach, duodenum, small bowel, and colon when reduced ability to move.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
o By Product Type
o By Application
o By Distribution Channel
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- including Amgen Inc., Pfizer, Inc., Lilly USA, LLC, Xeris Biopharma Holdings, Inc., and others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Glucagon Market Report Segment
By Product Type
- Injectable
- Nasal
By Application
- Emergency Kits
- General Use
- Diagnostics and Motility
- Others (Cardiogenic Shock)
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
A full report of Glucagon Market is available at: https://www.omrglobal.com/industry-reports/glucagon-market
Glucagon Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Amgen Inc.
- Amphastar Pharmaceuticals
- Avalon Pharma Pvt. Ltd.
- Bachem Holding AG
- Fresenius SE & Co. KGaA
- FUJIFILM Holdings Corp.
- Lilly USA, LLC
- Novo Nordisk A/S
- Svar Life Science AB
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
